Objectives: Dilated cardiomyopathy (DCM) is one of the leading causes of heart failure with high morbidity and mortality. Although more than 40 genes have been reported to cause DCM, the role of genetic testing in clinical practice is not well defined. Mutations in the troponin T (TNNT2) gene represent an important subset of known disease-causing mutations associated with DCM. Therefore, the aim of the present study was to determine the genetic variations in TNNT2 and the associations of those variations with DCM in Chinese patients. Methods: An approximately 4 kb fragment of the TNNT2 gene was isolated from 103 DCM patients and 192 healthy controls and was analyzed by DNA sequence analysis for genetic variations. Results: A total of 6 TNNT2 variants were identified in 99 patients, including a G321T missense mutation (Leu84Phe) and 5 novel intronic variants. Alleles of two novel SNPs (c.192+353 C>A, OR¼0.095; 95% CI: 0.013-0.714, P¼0.022; c.192+463 G>A, OR¼0.090, 95% CI: 0.012-0.675, P¼0.019) and SNP rs3729843 (OR¼1.889, 95% CI: 1.252-2.852; P¼0.002) were significantly correlated with DCM. Conclusions: These results suggest that variations in the TNNT2 gene might be associated with DCM in the Chinese population.
Objectives: Declined vasorelaxation function in aging resistance arteries is responsible for aging related multiple organ dysfunctions. The aim of the present study is to explore the role of peroxynitrite (ONOO -) in aging resistance arterial vasorelaxation dysfunction and the possible mechanism. Methods: In the present study, young (3-4 months olds) and aging (20 months olds) male SD rats were randomly randomized to receive vehicle (Saline) or FeTMPyP (ONOOscavenger) for 2 weeks. The vasorelaxation of resistance arteries was determined in vitro; NOx level was tested by a colorimetric assay; the expression of nitrotyrosine (NT), soluble Guanylate Cyclase (sGC), vasodilator-stimulated phosphoprotein (VASP) and phosphorylated VASP (P-VASP) in resistance arteries was detected by immunohistochemical staining.
Results: In the present study, endothelium dependent dilation in aging resistance arteries was lower than young rats (young vs. aging: 68.0%AE4.5% vs. 50.4%AE2.9%, P<0.01). And the endothelium independent dilation remained constant. Nitrative stress was increased in aging resistance arteries, evidenced by elevated NOx level in serum from aging rats (nmol/ml; young vs. aging: 3.3AE1.4 vs. 5.3AE1.0, P<0.05) and increased NT level (P<0.05). ONOOwas responsible for the vasorelaxation dysfunction, evidenced by normalized vasorelaxation after inhibit ONOOor its sources (P<0.05) and suppressed NT expression after FeTMPyP treatment (P<0.05). The expression of sGC was not significantly different between young and aging resistance arteries, but the P-VASP/VASP ratio (biochemical marker of NO-sGC-cGKs signaling) decreased, which was reversed by FeTMPyP treatment in vivo (P<0.05).
Conclusions:
The present study suggested that ONOOis responsible for the decline of endothelial dependent vasorelaxation in aging resistance arteries, and this effect likely involves the dysfunction of the NO-sGC-cGKs pathway.
GW25-e4153
Silk fibroin/chitosan nanofibers based adipose tissue-derived mesenchymal stem cell patches prevent myocardial remodeling after myocardial infarction in rat Objectives: To fabricate novel biocompatible silk fibroin/chitosan (SF/CS) nanofibers seeded with adipose tissue-derived mesenchymal stem cells (AD-MSCs) for cardiac tissue regeneration. Methods: Silk fibroin with good elasticity and chitosan as hydrophile were assembled onto the cellulose electrospun mat via layer-by-layer method. The micro-structure of the nanofibers was characterized by X-ray photoelectron spectroscopy (XPS) and scanning electron microscope (SEM). AD-MSCs were isolated from Fluc-EGFP transgenic mice constitutively expressing both firefly luciferase (Fluc) and enhanced green fluorescent protein (EGFP). Rat model of acute myocardial infarction (AMI) was induced by ligation of the left anterior descending coronary artery. The SF/CS nanofibrous patches (9Â9mm 2 ) seeded with or without ADMSCs (seeding density: 2Â10 5 cells/patch) were adhered onto the epicardium of the infarcted region. Wild type Sprague Dawley rats (male, 120-140g) were randomized into four groups (each n¼10) : Sham group, MI group, MI/SF/CS group and MI/ADMSC/SF/CS group (MI hearts with implantations of SF/CS and ADMSC/SF/CS patches respectively). Three days post-operation, cardiomyocyte apoptosis and the paracrine factors in the periinfarct area was determined by TUNEL staining and by ELISA assay respectively. The viability of engrafted AD-MSCs was tracked using longitudinal bioluminescence imaging (BLI) and cardiac function was measured by transthoracic echocardiography (TTE) 1, 7, 14 and 28 days post-operation. Four weeks after AMI operation, H&E, Masson's Trichrome, Troponin I, CD68 and CD31 immunofluorescence stainings were performed to evaluate myocardium fibrosis, tissue regeneration, neovascularization and inflammatory reaction. Results: BLI showed AD-MSCs were detectable until four weeks after transplantation. By TTE, ADMSC/SF/CS patches improved left ventricular ejection fraction (LVEF) (sham: 73AE2%, MI: 24AE3%, MI/SF/CS: 38AE3%, MI/ADMSC/SF/CS: 53AE4%; n¼10 per group; P<0.05, four weeks post-operation). The implantation of ADMSC/SF/CS patches decreased cardiomyocyte apoptosis (P<0.05) and increased the secretion of paracrine factors (P<0.05). Four weeks after operation, the patches in both groups were intactly adhered on the MI zones with minor inflammatory as compared with MI group (P<0.05), while angiogenesis was improved (P<0.05) and fibrosis size was reduced (sham: 0, MI: 23AE4%, MI/SF/CS: 15AE2%, MI/ADMSC/SF/CS: 9 AE3 %; n¼10 per group; P<0.05). Furthermore, EGFP+ cardiomyocytes (cTn I-positive) and endothelial cells (CD31-positive) could be identified in MI/ADMSC/SF/CS group. Conclusions: This study demonstrated that the SF/CS nanofibers provide threedimensional microenvironments and scaffold to support the retention and viability of engrafted ADMSCs, synergistically promote the therapeutic efficiency to alleviate cardiac fibrosis, attenuate ventricular remodeling and induce angiogenesis and cardiomyocyte regeneration.
GW25-e4155
Rb1 protects endothelial cells from hydrogen peroxide-induced cell injury by modulating PAI-1 expression Objectives: Oxidative stress can induce endothelial cell injury. Plasminogen activator inhibitor-1 (PAI-1), a serine protease inhibitor, accelerates thrombus formation upon ruptured atherosclerotic plaques. However, it is not known whether or not ginsenoside Rb1 inhibits PAI-1 production induced by H 2 O 2 in endothelial cells. In present study, we investigated that Rb1 may have an inhibitory effect on PAI-1 production induced by H 2 O 2 and have protective effects on H 2 O 2 -induced endothelial injury. Methods: Primary human umbilical vein endothelial cells (HUVECs) injury was induced by H 2 O 2 . PAI-1 mRNA and protein expression were analyzed by real time PCR and Western blot. Results: Rb1 was found to protect endothelial injury, as witnessed by a significant increase of cell numbers. Rb1 could markedly decrease PAI-1 mRNA expression by 1.56-fold compared with cells treated with H 2 O 2 alone after 24-hour incubation (P<0.01). Meanwhile, PAI-1 protein expression decreased in the 20mM Rb1pretreated cells by 1.39-fold compared to that in cells treated with H 2 O 2 alone (P<0.01). Conclusions: Our report demonstrates that Rb1 can exert protective effects on H 2 O 2induced cellular injury through modulating PAI-1 expression.
GW25-e4168
Dipeptidyl peptidase (DPP) -4 inhibitor exhibits anti-apoptosis effects in isoproterenol-induced myocardial infarcted rats by inhibiting oxidative stress Guo Bingyan, Li Yongjun The Second Hospital of Hebei Medical University Objectives: Cardiac apoptosis plays an important role in the pathology of myocardial infarction. The protective effects of Dipeptidyl peptidase (DPP) -4 inhibitor (vildagliptin) on cardiac apoptosis were evaluated in isoproterenol induced myocardial infarcted rats. Methods: Male Wistar rats are treated intravenously with Vildagliptin (2 mg/kg/day) daily for a period of 21 days. After 21 days of pretreatment, isoproterenol (100 mg/kg) was injected subcutaneously to rats at an interval of 24 h for 2 days (on 22th and 23th day) to induce myocardial infarction. Cardiac diagnostic markers, heart lipid peroxidation, antioxidant system, histopathological changes of the heart and apoptosis were evaluated in isoproterenol induced myocardial infarcted rats. Results: Isoproterenol induced myocardial infarcted rats showed a significant increase in the levels of serum cardiac diagnostic markers, heart lipid peroxidation products and a significant decrease in the activities/levels of heart antioxidants, compared with normal rats. Additionally, Histopathological findings of myocardial infarcted rats revealed marked necrosis. Real Time Polymerase Chain Reaction study revealed an increase in the myocardial expression of Bax, caspase-8, caspase-9 and Fas genes and a decrease in the myocardial expression of Bcl-2 and Bcl-xL genes.Vildagliptin (2 mg/kg/day) pretreatment decreased the levels of serum cardiac marker enzymes, reduced heart lipid peroxidation and minimized the alterations the activities/levels of heart antioxidants of isoproterenol-induced myocardial infarcted rats. Histopathological study evidenced that the pretreatment with Vildagliptin inhibited myocardial damage. Vildagliptin pretreatment also showed protective effects on apoptosis. The in vitro study also revealed the free radical scavenging and anti-apoptosis activity of Vildagliptin. Conclusions: Thus, Vildagliptin protected the myocardial infarcted rat's heart against apoptosis by inhibiting oxidative stress.
GW25-e4228
Effect of metoprolol on expression and vasodilatation function of AT2R in SHR Objectives: The interactional relationship between the sympathetic nervous systems (SNS) and the renin-angiotensin-aldosterone system (RAS) has been revealed but poorly investigated. The present work was designed to explore the effect of metoprolol (MET) treatment on the RAS, especially the expression and vasomotor function of AT2R, in spontaneously hypertensive rats (SHR). Methods: SHR was treated with metoprolol for 4 weeks. The dynamic changes of the blood pressure, renin activity, Ang II concentration and AT2R expression were investigated. Superior mesenteric resistance arteries were isolated for determining the protein expression of AT1R and AT2R. Perfusion experiment was carried out to explore the vasomotor function of AT2R. Results: The results showed that up-regulated renin activity and Ang II concentration of plasma in SHR were inhibited by metoprolol treatment. In isolated superior mesenteric arteries from both WKY and SHR, Ang II perfusion induced vasodilatation after AT1R inhibition by telmisartan, although the vasodilatation was harmed in SHR. Furthermore, AT2R inhibitor PD123319 arrested the vasodilatation induced by Ang II. SHR received metoprolol exerted improved vasodilatation mediated by AT2R (47.29AE5.16% versus 24.99AE4.93% for MET and SHR, respectively, P<0.05). Western blot analysis showed that metoprolol restored expression of AT2R in SHR, which may contribute to metoprolol's antihypertensive effect.
Conclusions:
These results suggested an impact of b-adrenergic blocker on RAS and supported an important role of AT2R in antihypertensive treatment.
GW25-e4266
Action and Mechanism of Secreted Frizzled-Related Protein 5 in Cardiomyocyte Hypertrophy
Jin Xin, Bingyan Guo, Yongjun Li The Second Hospital of Hebei Medical University
Objectives: Secreted frizzled-related protein 5 (Sfrp5) has been described as novel adipokine with anti-inflammatory properties at present. However, it's expression and protection mechanisms in the cardiomyocyte hypertrophy at the cellular level are not thoroughly understood. Here, the authors report for the first time by means of angiotensin II induced cardiomyocyte hypertrophy in vitro that the expression and mechanisms of Sfrp5.
Methods: Cardiomyocytes were preincubated with Ang II through primary culture of cardiac cells of neonatal SD rats. Telmisartan and PD123319 were used to block Ang II type-1 and type-1 receptors respectively. Rho proteins have been suggested as major contributors to cardiac hypertrophy. Here, inhibition of the Rho/ROCK pathway by Y-27632, a selective inhibitor of ROCK, we determined the hypothesis that Rho and Rho-associated kinase (Rho/ROCK) as mediators of the expression of sFRP5 in angiotensin II (Ang II) -induced cardiomyocyte hypertrophy. Reverse transcriptionpolymerase chain reaction and Western blot were used to estimate the expression of sfRP5, brain natriuretic peptide (BNP) and phosphorylation of MYPT-1. Results: sFRP5 was discovered expressed in cardiomyocytes. Ang II treatment induced the increased expression of sFRP5 and BNP in a dose-and time-dependent manner in cardiomyocytes, after preincubating with AT1-R antagonist telmisartan completely blocked Ang II-induced sFRP5 expression increasement. The recession of phosphorylation of MYPT-1 (P-MYPT 1) and sFRP5 were expressed after inhibiting of Rho/ROCK. Conclusions: The increased sFRP5 expression was mainly through the AT1-R-Rho/ ROCK signal pathway in the process of Ang IIinduced cardiomyocyte hypertrophy.
GW25-e4339
The research on antihypertensive effect of metoprolol influenced by knockdown of b1-AR in myocardial tissue of Spontaneously Hypertensive Rats showing that 100% identical to its accession number. The plasmid was then packaged to recombinant adeno-associated virus named AAV9-shRNA-ADRB1-ZsGreen and harvested (viral titer was 1.5x10 12 vg/ml). (2) Spontaneousely Hypertensive Rats treatments; 36 SHRs were grouped into six randomly as follows:Group 1, AAV9-shRNA-ADRB1-ZsGreen + metoprolol (n¼6); Group2, AAV9-shRNA-ADRB1-ZsGreen+saline (n¼6); Group 3, AAV9-CMV-ADRB1-ZsGreen + metoprolol (n¼6); Group 4, AAV9-CMV-ADRB1-ZsGreen + saline Group (n¼6); Group 5, sham + metoprolol Group (n¼6); Group 6, sham + saline (n¼6). Metoprolol were given by gavage in 50mg/kg/d dose. All of them were monitored their blood pressure weekly. Rats were killed and dissected the myocardial tissue after 4 weeks. (3) The research on the expression of b1-AR in myocardial tissue among all rats groups in transcription and translation levels, Real-time RT-PCR, Immunohistochemistry and Western blot were used to assay the expression of b1-AR gene. Results: (1) Comparison of the b1-AR expression among each group: Real-time RT-PCR results showed that AAV9-shRNA-ADRB1-ZsGreen injection could significantly decrease b1-AR mRNA expression compared with the negative control group (P <0.05) Immunohistochemistry results showed that it could significantly decrease theb1-AR protein expression compared with the negative control and sham group (P <0.05 ), Western blot results showed that it also could significantly decrease the b1-AR protein expression compared with the negative control group (P <0.05).
(2) Comparison of the antihypertensive effects among each group: After 4 weeks of the intervention, systolic blood pressure in group 1, group 2, group 3, group 5 was significantly lower than group 4 and group 6 (P<0.05); After 4 weeks of metoprolol intervention, the SBP drop pressure amplitude of AAV9-shRNA-ADRB1-ZsGreen injection group were significantly lower than the negative control group and the sham group (22.84AE1.72 vs.28.78AE2.72 vs.30.16AE5.71, P<0.05).
Conclusions:
(1) The AAV9-shRNA-ADRB1-ZsGreen is successfully constructed and it can significantly reduce the b1-AR expression in myocardial of SHRs. (2) Knockdown of b1-AR in myocardial tissue of Spontaneousely Hypertensive Rats resulted in worse antihypertensive response to metoprolol; it may be one of the reasons for influencing individual antihypertensive response to metoprolol.
GW25-e4377

Expression of ZO-1 in iPS cells Mediated by Lentiviral Vector
Sheng Tao 1 , Li Hui 2 , Sun Zhi-Shan 2 , Zeng Jian-Ping 2 1 The Second Xiangya Hospital of Central South University, 2 Xiangtan Central Hospital Objective: The fundamental researches of cardiovascular disease verified that intercalated disc-related gene ZO-1varis in different myocardial pathologic conditions, and it interacts with Cx43. This research is about to construct recombinant lentivirus over-expressing vector of porcine ZO-1 gene, to infect iPS cells, to obtain iPS cells carrying this target gene. Methods: The ZO-1gene sequence publicated on Gendbank was analyzed, and designed a couple of primer containing both BamHI and SalI. The porcine ZO-1 gene was amplified by PCR, and cloned into lentiviral expression vector, to construct the recombinant Lenti-EF1a-EGFP-TRE-ZO1 vector; the vector was confirmed by DNA sequencing. The production of lentivirus was obtained by using pVSVG, delta 8.91and fugene to contransfect 293T cells. The titer of lentivirus was testd with fluorescent expression, to infect iPS cells.
